Sponsor Pipeline

Akiva Mintz Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
5
Recruiting
4
Disease Areas
Active Trials by Phase
Phase 2
7
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06904313 Ultralow Dose PET Imaging for PSMA Expression Healthy Volunteer Recruiting
NCT06956391 Ultralow Dose PET Imaging of 18F-FDG Uptake Healthy Volunteer Recruiting
NCT07284563 Ultralow Dose PET Imaging for 18F-NaF Uptake Healthy Volunteer Recruiting
NCT07284589 Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake Healthy (Controls) Recruiting
NCT07012993 Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol Alzheimer Disease Recruiting
NCT07284576 Ultralow Dose PET Imaging of 18F-flurpiridaz Healthy Volunteer Enrolling by Invitation
NCT07542158 Ultralow Dose PET Imaging of 18F-FDOPA Heathy Volunteer Enrolling by Invitation
Disease Areas
Alzheimer's Disease (1) Dementia (1) Glioma (1) Parkinson's Disease (1)
Get alerts when Akiva Mintz's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free